Carregant...

Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of the Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop

Pancreatic cancer is the fourth leading cause of cancer death in the United States and the five-year relative survival for patients diagnosed with pancreatic cancer is less than 10%. Early intervention is the key to a better survival outcome. Currently, there are no biomarkers that can reliably dete...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pancreas
Autors principals: Young, Matthew R., Wagner, Paul D., Ghosh, Sharmistha, Rinaudo, Jo Ann, Baker, Stuart G., Zaret, Kenneth S., Goggins, Michael, Srivastava, Sudhir
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777224/
https://ncbi.nlm.nih.gov/pubmed/29346214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000973
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!